Neuroone Medical Technologies Corp Cash Flow Conversion Efficiency
Neuroone Medical Technologies Corp cash flow conversion efficiency. Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has a cash flow conversion efficiency ratio of -0.247x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.33 Million) by net assets ($5.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Neuroone Medical Technologies Corp (2010–2025)
Cash flow conversion efficiency of Neuroone Medical Technologies Corp from 2010 to 2025. This chart illustrates how Neuroone Medical Technologies Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Neuroone Medical Technologies Corp stock price for real-time trading data and today's change.
Neuroone Medical Technologies Corp Cash Flow Conversion Ratio Explained
Neuroone Medical Technologies Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Neuroone Medical Technologies Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuroone Medical Technologies Corp ranked by their cash flow conversion efficiency. Also see NMTC company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kamdar Group (Malaysia) Bhd
KLSE:8672
|
0.002x |
|
Peako Ltd
AU:PKO
|
-0.629x |
|
Polar Capital Holdings plc
LSE:POLR
|
0.460x |
|
Mobotix AG
F:MBQ
|
N/A |
|
Vitura Health Ltd
AU:VIT
|
-0.030x |
|
Zaklady Urzadzen Kotlowych Staporkow SA
WAR:ZUK
|
0.030x |
|
Lima Dua Lima Tiga PT
JK:LUCY
|
-0.211x |
|
American Manganese Inc
V:AMY
|
-0.045x |
Annual Cash Flow Conversion Efficiency for Neuroone Medical Technologies Corp (2010–2025)
The table below shows the annual cash flow conversion efficiency of Neuroone Medical Technologies Corp from 2010 to 2025. Review Neuroone Medical Technologies Corp free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $7.07 Million | $-2.84 Million | -0.401x | +97.01% |
| 2024-09-30 | $822.01K | $-11.01 Million | -13.396x | -549.64% |
| 2023-09-30 | $6.25 Million | $-12.89 Million | -2.062x | -163.38% |
| 2022-09-30 | $9.60 Million | $-7.52 Million | -0.783x | +40.35% |
| 2021-09-30 | $6.55 Million | $-8.60 Million | -1.313x | +20.82% |
| 2020-09-30 | $2.07 Million | $-3.43 Million | -1.658x | -138.02% |
| 2019-09-30 | $-1.24 Million | $-5.40 Million | 4.360x | +577.83% |
| 2018-09-30 | $-4.40 Million | $-2.83 Million | 0.643x | +711.35% |
| 2017-09-30 | $-266.22K | $-21.11K | 0.079x | -78.63% |
| 2016-09-30 | $-81.49K | $-30.23K | 0.371x | -49.84% |
| 2015-09-30 | $-35.39K | $-26.17K | 0.740x | -16.60% |
| 2014-09-30 | $-28.30K | $-25.09K | 0.887x | +11.30% |
| 2013-09-30 | $-17.24K | $-13.73K | 0.797x | 0.00% |
| 2012-09-30 | $-17.24K | $-13.73K | 0.797x | -90.48% |
| 2011-09-30 | $-3.28K | $-27.43K | 8.370x | +610.58% |
| 2010-09-30 | $-4.32K | $-5.09K | 1.178x | -- |
About Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more